The Patent Finder

EnGeneIC Molecular Delivery Pty Ltd

Also on record
Records under this name other than the patents EnGeneIC Molecular Delivery Pty Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Back to EnGeneIC Molecular Delivery Pty Ltd

PatentTitleStatus Expires Confidence
US 8,772,013Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
Term ended
Term ended May 11, 2026 · From the USPTO record
Term endedTerm ended May 11, 2026From the USPTO record
US 8,735,566Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
Term ended
Term ended Jan 14, 2026 · From the USPTO record
Term endedTerm ended Jan 14, 2026From the USPTO record
US 8,669,101Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
Term ended
Term ended Oct 12, 2025 · From the USPTO record
Term endedTerm ended Oct 12, 2025From the USPTO record
US 8,956,864Bacterially Derived Intact Minicells That Encompass Plasmid Free Functional Nucleic Acid for in Vivo Delivery to Mammalian Cells
Term ended
Ended no later than Aug 25, 2025 · Low confidence
Term endedEnded no later than Aug 25, 2025Low confidence
US 9,066,982Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
Term ended
Ended no later than Aug 25, 2025 · From the USPTO record
Term endedEnded no later than Aug 25, 2025From the USPTO record
US 9,242,007Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Term ended
Term ended Aug 25, 2025 · From the USPTO record
Term endedTerm ended Aug 25, 2025From the USPTO record
US 9,730,897Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Term ended
Term ended Aug 25, 2025 · From the USPTO record
Term endedTerm ended Aug 25, 2025From the USPTO record
US 10,098,847Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
Term ended
Ended no later than Aug 25, 2025 · From the USPTO record
Term endedEnded no later than Aug 25, 2025From the USPTO record
US 10,383,827Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
Term ended
Term ended Aug 25, 2025 · From the USPTO record
Term endedTerm ended Aug 25, 2025From the USPTO record
US 10,426,736Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Term ended
Ended no later than Aug 25, 2025 · From the USPTO record
Term endedEnded no later than Aug 25, 2025From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited